NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.03
+0.21 (1.18%)
Nov 4, 2024, 4:00 PM EST - Market closed

NAMS Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-229.4-176.94-22.63-41.79-5.75
Depreciation & Amortization
0.060.050.010.010
Other Amortization
---0.16-
Asset Writedown & Restructuring Costs
--87.22-
Stock-Based Compensation
27.6124.574.121.24-
Other Operating Activities
34.375.2310.8-0.820.31
Change in Accounts Payable
-85.074.816.560.83
Change in Unearned Revenue
-7.42-8.7118.43--
Change in Other Net Operating Assets
-5.859.5-12.86-2.09-1.36
Operating Cash Flow
-188.63-141.2210.67-29.51-5.97
Capital Expenditures
-0.61-0.02-0.22-0.02-0.01
Investing Cash Flow
-0.61-0.02-0.22-0.02-0.01
Short-Term Debt Issued
--0.75-11.32
Total Debt Issued
--0.75-11.32
Net Debt Issued (Repaid)
--0.75-11.32
Issuance of Common Stock
204.538.91306.48--
Other Financing Activities
-0.52--5.79--
Financing Cash Flow
203.028.91391.9184.711.32
Foreign Exchange Rate Adjustments
0.225.055.25-4.680.02
Net Cash Flow
14-127.28407.650.495.36
Free Cash Flow
-189.24-141.2410.44-29.54-5.98
Free Cash Flow Margin
-2548.99%-1002.43%10.17%--
Free Cash Flow Per Share
-2.17-1.720.55-2.69-1.20
Cash Interest Paid
--0.28--
Cash Income Tax Paid
0.030.03---
Levered Free Cash Flow
-108.42-7222.7-15.94-
Unlevered Free Cash Flow
-108.42-7222.88-15.84-
Change in Net Working Capital
5.05-17.76-21.14-4.83-
Source: S&P Capital IQ. Standard template. Financial Sources.